Results 251 to 260 of about 33,392 (283)
Effectiveness of drug-loaded poly(ethylene glycol) and poly(lactic-co-glycolic-acid) nanoparticles in the <i>in vitro</i> treatment of breast cancer: a systematic review. [PDF]
Front PharmacolSandoval-Vásquez C +12 more
europepmc +1 more source
The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer. [PDF]
Cancer MedBiteghe FAN +11 more
europepmc +1 more source
Folate-Functionalized Polymeric Nanoparticles for 5‑Fluorouracil Delivery to Prostate Cancer: Physicochemical and In Vitro/In Vivo Characterization. [PDF]
ACS OmegaBhatt B +6 more
europepmc +1 more source
Noncovalent PEGylation of l-Asparaginase Using PEGylated Polyelectrolyte
Noncovalent PEGylation of l-Asparaginase Using PEGylated Polyelectrolyteopenaire
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinics in Liver Disease, 2003
In summary, pegylated IFNs have a longer half-life, reduced immunogenicity, better pharmacokinetics, and enhanced biological activity when compared with standard IFN. Better adherence rates are feasible because of the once weekly administration of pegylated IFN. The adverse event profile is largely comparable. The improved pharmacokinetics of pegylated
Umaprasanna S, Karnam, K Rajender, Reddy
openaire +4 more sources
In summary, pegylated IFNs have a longer half-life, reduced immunogenicity, better pharmacokinetics, and enhanced biological activity when compared with standard IFN. Better adherence rates are feasible because of the once weekly administration of pegylated IFN. The adverse event profile is largely comparable. The improved pharmacokinetics of pegylated
Umaprasanna S, Karnam, K Rajender, Reddy
openaire +4 more sources
Expert Opinion on Emerging Drugs, 2009
PEGylation is a pharmaceutical technology that involves the covalent attachment of polyethylene glycol (PEG) to a drug to improve its pharmacokinetic, pharmacodynamic, and immunological profiles, and thus, enhance its therapeutic effect. Currently, PEGylation is used to modify proteins, peptides, oligonucleotides, antibody fragments, and small organic ...
Jung Seok, Kang +2 more
openaire +2 more sources
PEGylation is a pharmaceutical technology that involves the covalent attachment of polyethylene glycol (PEG) to a drug to improve its pharmacokinetic, pharmacodynamic, and immunological profiles, and thus, enhance its therapeutic effect. Currently, PEGylation is used to modify proteins, peptides, oligonucleotides, antibody fragments, and small organic ...
Jung Seok, Kang +2 more
openaire +2 more sources
PEGylated Inorganic Nanoparticles
Angewandte Chemie International Edition, 2011AbstractApplication of inorganic nanoparticles in diagnosis and therapy has become a critical component in the targeted treatment of diseases. The surface modification of inorganic oxides is important for providing diversity in size, shape, solubility, long‐term stability, and attachment of selective functional groups.
Karakoti, Ajay S. +3 more
openaire +3 more sources
PEGylated Polyester-Based Nanoncologicals
Current Topics in Medicinal Chemistry, 2014Several PEGylated polyester-based nanoncologicals have been proposed in the literature, some of them nowadays being under preclinical/clinical trials or marketed. In this review, we describe the main features of PEGylated polyesters and their correspondent nanocarriers.
CONTE, CLAUDIA +4 more
openaire +4 more sources
Purification of PEGylated Proteins, with the Example of PEGylated Lysozyme and PEGylated scFv
2014PEGylation is a common and highly accepted possibility for half-life prolongation of proteins by increasing the hydrodynamic size. The chromatographic purification of PEGylated protein, using PEG (poly-ethylene glycol) of different PEG chain lengths, with the example of lysozyme and a scFv, is described in detail here, and helpful suggestions for the ...
Anna, Moosmann +2 more
openaire +2 more sources